Back to Search
Start Over
Late infections and secondary malignancies after bendamustine/rituximab or RCHOP/RCVP chemotherapy for B-cell lymphomas.
- Source :
-
American journal of hematology [Am J Hematol] 2018 Jan; Vol. 93 (1), pp. E1-E3. Date of Electronic Publication: 2017 Oct 19. - Publication Year :
- 2018
- Subjects :
- Aged
Antineoplastic Combined Chemotherapy Protocols adverse effects
Bendamustine Hydrochloride adverse effects
Bendamustine Hydrochloride therapeutic use
Cyclophosphamide adverse effects
Cyclophosphamide therapeutic use
Doxorubicin adverse effects
Doxorubicin therapeutic use
Female
Humans
Infections chemically induced
Lymphoma, B-Cell complications
Male
Middle Aged
Neoplasms, Second Primary chemically induced
Prednisone adverse effects
Prednisone therapeutic use
Rituximab adverse effects
Rituximab therapeutic use
Vincristine adverse effects
Vincristine therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Lymphoma, B-Cell drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1096-8652
- Volume :
- 93
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- American journal of hematology
- Publication Type :
- Report
- Accession number :
- 28960532
- Full Text :
- https://doi.org/10.1002/ajh.24921